Vertex Pharmaceuticals (VRTX)
NASDAQ:VRTX
Holding VRTX?
Track your performance easily

Vertex Pharmaceuticals (VRTX) Cash flow

5,600 Followers

Vertex Pharmaceuticals Cash Flow

VRTX's free cash flow for Q2 2024 was $-3.82B. For the 2024 fiscal year, VRTX's free cash flow was decreased by $-703.80M and operating cash flow was $-3.75B. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -946.50M$ 3.54B$ 4.19B$ 2.65B$ 3.25B$ 1.57B
Investing Cash Flow
$ -3.60B$ -3.14B$ -378.60M$ -344.00M$ 99.40M$ -1.24B
Financing Cash Flow
$ -1.00B$ -562.20M$ -67.70M$ -1.48B$ -505.30M$ 126.77M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 35.25B$ 10.37B$ 10.51B$ 6.80B$ 5.99B$ 3.12B
Income Tax Paid Supplemental Data
$ 1.59B$ 1.68B$ 1.06B$ 476.30M$ 191.80M$ 24.73M
Interest Paid Supplemental Data
$ 40.80M$ 43.10M$ 52.30M$ 56.30M$ 54.50M$ 55.55M
Issuance Of Capital Stock
-----$ 343.24M
Issuance Of Debt
$ -50.20M$ -44.90M$ -85.50M$ -47.00M$ 13.30M$ 10.05M
Repayment Of Debt
$ -38.90M$ -44.90M$ -85.50M$ -47.00M$ -42.30M$ -39.19M
Free Cash Flow
$ -2.47B$ 3.28B$ 3.98B$ 2.41B$ 2.99B$ 1.49B
Domestic Sales
------
Foreign Sales
------
Currency in USD

Vertex Pharmaceuticals Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis